Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

The Nitrosamine Risk Assessment Questionnaire for APIs is an indispensable tool for pharmaceutical manufacturers. It provides a structured approach to identifying potential sources of nitrosamine contamination and implementing effective mitigation strategies.
In the pharmaceutical industry, managing Standard Operating Procedures (SOPs) is increasingly complex due to regulatory demands. This article highlights the challenges of SOP retrieval and showcases how the AI-driven Zamann Retrieval Augmented System (ZaRAS) transforms SOP management through enhanced efficiency,
Understanding the conditions that lead to nitrosamine formation is crucial for reducing their presence in our food. This article explores the science behind nitrosamine formation in cured meats and offers practical tips for minimizing their levels, ensuring a safer and
In the world of diagnostics, accuracy is paramount. For In Vitro Diagnostics (IVD) used in countless medical procedures, robust Quality Assurance (QA) practices are essential. These procedures ensure compliance with specific regulations and rigorous testing methods. The result? Reliable tools
Performance Qualification (PQ) is a vital process in the pharmaceutical industry, ensuring that equipment operates effectively under real-world conditions. This guide walks you through the essential steps to perform PQ, from writing a robust protocol to meeting FDA requirements. Explore
The qualification of a GMP facility is essential to ensure the high standards of pharmaceutical production and to guarantee product quality. In our latest article, you will learn the 10 most important steps for the successful qualification of a new
Navigating NDSRI regulatory reporting requirements is crucial for pharmaceutical companies to ensure compliance and patient safety. These regulations mandate timely and accurate reporting of nitrosamine impurities in medicines. Understanding the timeline for these requirements helps streamline processes and avoid costly
In the world of medical devices, where even minor flaws can have life-altering consequences, a robust Quality Management System (QMS) is paramount. This system ensures consistent quality, adherence to regulations, and ultimately, patient safety. While various standards exist, ISO 9001